Global Pediatric Vaccines Market Growth 2023-2029

February 2023 | 121 pages | ID: G376C6664C88EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Pediatric Vaccines Industry Forecast” looks at past sales and reviews total world Pediatric Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Pediatric Vaccines sales for 2023 through 2029. With Pediatric Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Pediatric Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pediatric Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric Vaccines.

The global Pediatric Vaccines market size is projected to grow from US$ 29080 million in 2022 to US$ 43480 million in 2029; it is expected to grow at a CAGR of 43480 from 2023 to 2029.

United States market for Pediatric Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pediatric Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pediatric Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pediatric Vaccines players cover GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic and Baxter, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Diphtheria
• Influenza
• Hepatitis
• Pneumococcal Diseases
• Meningococcal Diseases
• Others

Segmentation by application

• Newborn
• Infant
• Child
• Dolescent

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi
• AstraZeneca
• Novartis
• Takeda Pharmaceutical
• Bavarian Nordic
• Baxter
• LG Life Sciences
• Lupin
• S K Chemicals
• Mitsubishi Tanabe Pharma
• Janssen
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Bharat Biotech
• Crucell
• Dynavax
• Serum Institute of India

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pediatric Vaccines market?

What factors are driving Pediatric Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pediatric Vaccines market opportunities vary by end market size?

How does Pediatric Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pediatric Vaccines Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Pediatric Vaccines by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Pediatric Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Pediatric Vaccines Segment by Type
  2.2.1 Diphtheria
  2.2.2 Influenza
  2.2.3 Hepatitis
  2.2.4 Pneumococcal Diseases
  2.2.5 Meningococcal Diseases
  2.2.6 Others
2.3 Pediatric Vaccines Sales by Type
  2.3.1 Global Pediatric Vaccines Sales Market Share by Type (2018-2023)
  2.3.2 Global Pediatric Vaccines Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Pediatric Vaccines Sale Price by Type (2018-2023)
2.4 Pediatric Vaccines Segment by Application
  2.4.1 Newborn
  2.4.2 Infant
  2.4.3 Child
  2.4.4 Dolescent
2.5 Pediatric Vaccines Sales by Application
  2.5.1 Global Pediatric Vaccines Sale Market Share by Application (2018-2023)
  2.5.2 Global Pediatric Vaccines Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Pediatric Vaccines Sale Price by Application (2018-2023)

3 GLOBAL PEDIATRIC VACCINES BY COMPANY

3.1 Global Pediatric Vaccines Breakdown Data by Company
  3.1.1 Global Pediatric Vaccines Annual Sales by Company (2018-2023)
  3.1.2 Global Pediatric Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Pediatric Vaccines Annual Revenue by Company (2018-2023)
  3.2.1 Global Pediatric Vaccines Revenue by Company (2018-2023)
  3.2.2 Global Pediatric Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Pediatric Vaccines Sale Price by Company
3.4 Key Manufacturers Pediatric Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pediatric Vaccines Product Location Distribution
  3.4.2 Players Pediatric Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR PEDIATRIC VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Pediatric Vaccines Market Size by Geographic Region (2018-2023)
  4.1.1 Global Pediatric Vaccines Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Pediatric Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pediatric Vaccines Market Size by Country/Region (2018-2023)
  4.2.1 Global Pediatric Vaccines Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Pediatric Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pediatric Vaccines Sales Growth
4.4 APAC Pediatric Vaccines Sales Growth
4.5 Europe Pediatric Vaccines Sales Growth
4.6 Middle East & Africa Pediatric Vaccines Sales Growth

5 AMERICAS

5.1 Americas Pediatric Vaccines Sales by Country
  5.1.1 Americas Pediatric Vaccines Sales by Country (2018-2023)
  5.1.2 Americas Pediatric Vaccines Revenue by Country (2018-2023)
5.2 Americas Pediatric Vaccines Sales by Type
5.3 Americas Pediatric Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pediatric Vaccines Sales by Region
  6.1.1 APAC Pediatric Vaccines Sales by Region (2018-2023)
  6.1.2 APAC Pediatric Vaccines Revenue by Region (2018-2023)
6.2 APAC Pediatric Vaccines Sales by Type
6.3 APAC Pediatric Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pediatric Vaccines by Country
  7.1.1 Europe Pediatric Vaccines Sales by Country (2018-2023)
  7.1.2 Europe Pediatric Vaccines Revenue by Country (2018-2023)
7.2 Europe Pediatric Vaccines Sales by Type
7.3 Europe Pediatric Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pediatric Vaccines by Country
  8.1.1 Middle East & Africa Pediatric Vaccines Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Pediatric Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Pediatric Vaccines Sales by Type
8.3 Middle East & Africa Pediatric Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pediatric Vaccines
10.3 Manufacturing Process Analysis of Pediatric Vaccines
10.4 Industry Chain Structure of Pediatric Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pediatric Vaccines Distributors
11.3 Pediatric Vaccines Customer

12 WORLD FORECAST REVIEW FOR PEDIATRIC VACCINES BY GEOGRAPHIC REGION

12.1 Global Pediatric Vaccines Market Size Forecast by Region
  12.1.1 Global Pediatric Vaccines Forecast by Region (2024-2029)
  12.1.2 Global Pediatric Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pediatric Vaccines Forecast by Type
12.7 Global Pediatric Vaccines Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Information
  13.1.2 GlaxoSmithKline Pediatric Vaccines Product Portfolios and Specifications
  13.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 GlaxoSmithKline Main Business Overview
  13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
  13.2.1 Merck Company Information
  13.2.2 Merck Pediatric Vaccines Product Portfolios and Specifications
  13.2.3 Merck Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Merck Main Business Overview
  13.2.5 Merck Latest Developments
13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer Pediatric Vaccines Product Portfolios and Specifications
  13.3.3 Pfizer Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
13.4 Sanofi
  13.4.1 Sanofi Company Information
  13.4.2 Sanofi Pediatric Vaccines Product Portfolios and Specifications
  13.4.3 Sanofi Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Sanofi Main Business Overview
  13.4.5 Sanofi Latest Developments
13.5 AstraZeneca
  13.5.1 AstraZeneca Company Information
  13.5.2 AstraZeneca Pediatric Vaccines Product Portfolios and Specifications
  13.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 AstraZeneca Main Business Overview
  13.5.5 AstraZeneca Latest Developments
13.6 Novartis
  13.6.1 Novartis Company Information
  13.6.2 Novartis Pediatric Vaccines Product Portfolios and Specifications
  13.6.3 Novartis Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Novartis Main Business Overview
  13.6.5 Novartis Latest Developments
13.7 Takeda Pharmaceutical
  13.7.1 Takeda Pharmaceutical Company Information
  13.7.2 Takeda Pharmaceutical Pediatric Vaccines Product Portfolios and Specifications
  13.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Takeda Pharmaceutical Main Business Overview
  13.7.5 Takeda Pharmaceutical Latest Developments
13.8 Bavarian Nordic
  13.8.1 Bavarian Nordic Company Information
  13.8.2 Bavarian Nordic Pediatric Vaccines Product Portfolios and Specifications
  13.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Bavarian Nordic Main Business Overview
  13.8.5 Bavarian Nordic Latest Developments
13.9 Baxter
  13.9.1 Baxter Company Information
  13.9.2 Baxter Pediatric Vaccines Product Portfolios and Specifications
  13.9.3 Baxter Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Baxter Main Business Overview
  13.9.5 Baxter Latest Developments
13.10 LG Life Sciences
  13.10.1 LG Life Sciences Company Information
  13.10.2 LG Life Sciences Pediatric Vaccines Product Portfolios and Specifications
  13.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 LG Life Sciences Main Business Overview
  13.10.5 LG Life Sciences Latest Developments
13.11 Lupin
  13.11.1 Lupin Company Information
  13.11.2 Lupin Pediatric Vaccines Product Portfolios and Specifications
  13.11.3 Lupin Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Lupin Main Business Overview
  13.11.5 Lupin Latest Developments
13.12 S K Chemicals
  13.12.1 S K Chemicals Company Information
  13.12.2 S K Chemicals Pediatric Vaccines Product Portfolios and Specifications
  13.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 S K Chemicals Main Business Overview
  13.12.5 S K Chemicals Latest Developments
13.13 Mitsubishi Tanabe Pharma
  13.13.1 Mitsubishi Tanabe Pharma Company Information
  13.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolios and Specifications
  13.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Mitsubishi Tanabe Pharma Main Business Overview
  13.13.5 Mitsubishi Tanabe Pharma Latest Developments
13.14 Janssen
  13.14.1 Janssen Company Information
  13.14.2 Janssen Pediatric Vaccines Product Portfolios and Specifications
  13.14.3 Janssen Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Janssen Main Business Overview
  13.14.5 Janssen Latest Developments
13.15 Shenzhen Kangtai Biological Products
  13.15.1 Shenzhen Kangtai Biological Products Company Information
  13.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolios and Specifications
  13.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 Shenzhen Kangtai Biological Products Main Business Overview
  13.15.5 Shenzhen Kangtai Biological Products Latest Developments
13.16 Sinovac Biotech
  13.16.1 Sinovac Biotech Company Information
  13.16.2 Sinovac Biotech Pediatric Vaccines Product Portfolios and Specifications
  13.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Sinovac Biotech Main Business Overview
  13.16.5 Sinovac Biotech Latest Developments
13.17 Bharat Biotech
  13.17.1 Bharat Biotech Company Information
  13.17.2 Bharat Biotech Pediatric Vaccines Product Portfolios and Specifications
  13.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 Bharat Biotech Main Business Overview
  13.17.5 Bharat Biotech Latest Developments
13.18 Crucell
  13.18.1 Crucell Company Information
  13.18.2 Crucell Pediatric Vaccines Product Portfolios and Specifications
  13.18.3 Crucell Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.18.4 Crucell Main Business Overview
  13.18.5 Crucell Latest Developments
13.19 Dynavax
  13.19.1 Dynavax Company Information
  13.19.2 Dynavax Pediatric Vaccines Product Portfolios and Specifications
  13.19.3 Dynavax Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.19.4 Dynavax Main Business Overview
  13.19.5 Dynavax Latest Developments
13.20 Serum Institute of India
  13.20.1 Serum Institute of India Company Information
  13.20.2 Serum Institute of India Pediatric Vaccines Product Portfolios and Specifications
  13.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
  13.20.4 Serum Institute of India Main Business Overview
  13.20.5 Serum Institute of India Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pediatric Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pediatric Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Diphtheria
Table 4. Major Players of Influenza
Table 5. Major Players of Hepatitis
Table 6. Major Players of Pneumococcal Diseases
Table 7. Major Players of Meningococcal Diseases
Table 8. Major Players of Others
Table 9. Global Pediatric Vaccines Sales by Type (2018-2023) & (K Units)
Table 10. Global Pediatric Vaccines Sales Market Share by Type (2018-2023)
Table 11. Global Pediatric Vaccines Revenue by Type (2018-2023) & ($ million)
Table 12. Global Pediatric Vaccines Revenue Market Share by Type (2018-2023)
Table 13. Global Pediatric Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 14. Global Pediatric Vaccines Sales by Application (2018-2023) & (K Units)
Table 15. Global Pediatric Vaccines Sales Market Share by Application (2018-2023)
Table 16. Global Pediatric Vaccines Revenue by Application (2018-2023)
Table 17. Global Pediatric Vaccines Revenue Market Share by Application (2018-2023)
Table 18. Global Pediatric Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 19. Global Pediatric Vaccines Sales by Company (2018-2023) & (K Units)
Table 20. Global Pediatric Vaccines Sales Market Share by Company (2018-2023)
Table 21. Global Pediatric Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Pediatric Vaccines Revenue Market Share by Company (2018-2023)
Table 23. Global Pediatric Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 24. Key Manufacturers Pediatric Vaccines Producing Area Distribution and Sales Area
Table 25. Players Pediatric Vaccines Products Offered
Table 26. Pediatric Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Pediatric Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Pediatric Vaccines Sales Market Share Geographic Region (2018-2023)
Table 31. Global Pediatric Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Pediatric Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Pediatric Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Pediatric Vaccines Sales Market Share by Country/Region (2018-2023)
Table 35. Global Pediatric Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Pediatric Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
Table 38. Americas Pediatric Vaccines Sales Market Share by Country (2018-2023)
Table 39. Americas Pediatric Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Pediatric Vaccines Revenue Market Share by Country (2018-2023)
Table 41. Americas Pediatric Vaccines Sales by Type (2018-2023) & (K Units)
Table 42. Americas Pediatric Vaccines Sales by Application (2018-2023) & (K Units)
Table 43. APAC Pediatric Vaccines Sales by Region (2018-2023) & (K Units)
Table 44. APAC Pediatric Vaccines Sales Market Share by Region (2018-2023)
Table 45. APAC Pediatric Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Pediatric Vaccines Revenue Market Share by Region (2018-2023)
Table 47. APAC Pediatric Vaccines Sales by Type (2018-2023) & (K Units)
Table 48. APAC Pediatric Vaccines Sales by Application (2018-2023) & (K Units)
Table 49. Europe Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
Table 50. Europe Pediatric Vaccines Sales Market Share by Country (2018-2023)
Table 51. Europe Pediatric Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Pediatric Vaccines Revenue Market Share by Country (2018-2023)
Table 53. Europe Pediatric Vaccines Sales by Type (2018-2023) & (K Units)
Table 54. Europe Pediatric Vaccines Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Pediatric Vaccines Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Pediatric Vaccines Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Pediatric Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Pediatric Vaccines Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Pediatric Vaccines Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Pediatric Vaccines Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Pediatric Vaccines
Table 62. Key Market Challenges & Risks of Pediatric Vaccines
Table 63. Key Industry Trends of Pediatric Vaccines
Table 64. Pediatric Vaccines Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Pediatric Vaccines Distributors List
Table 67. Pediatric Vaccines Customer List
Table 68. Global Pediatric Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Pediatric Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Pediatric Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Pediatric Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Pediatric Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Pediatric Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Pediatric Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Pediatric Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Pediatric Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Pediatric Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Pediatric Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Pediatric Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Pediatric Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Pediatric Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. GlaxoSmithKline Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline Pediatric Vaccines Product Portfolios and Specifications
Table 84. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 85. GlaxoSmithKline Main Business
Table 86. GlaxoSmithKline Latest Developments
Table 87. Merck Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Merck Pediatric Vaccines Product Portfolios and Specifications
Table 89. Merck Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 90. Merck Main Business
Table 91. Merck Latest Developments
Table 92. Pfizer Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Pediatric Vaccines Product Portfolios and Specifications
Table 94. Pfizer Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Sanofi Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Pediatric Vaccines Product Portfolios and Specifications
Table 99. Sanofi Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 100. Sanofi Main Business
Table 101. Sanofi Latest Developments
Table 102. AstraZeneca Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. AstraZeneca Pediatric Vaccines Product Portfolios and Specifications
Table 104. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 107. Novartis Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis Pediatric Vaccines Product Portfolios and Specifications
Table 109. Novartis Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Novartis Main Business
Table 111. Novartis Latest Developments
Table 112. Takeda Pharmaceutical Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 113. Takeda Pharmaceutical Pediatric Vaccines Product Portfolios and Specifications
Table 114. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Takeda Pharmaceutical Main Business
Table 116. Takeda Pharmaceutical Latest Developments
Table 117. Bavarian Nordic Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 118. Bavarian Nordic Pediatric Vaccines Product Portfolios and Specifications
Table 119. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Bavarian Nordic Main Business
Table 121. Bavarian Nordic Latest Developments
Table 122. Baxter Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 123. Baxter Pediatric Vaccines Product Portfolios and Specifications
Table 124. Baxter Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Baxter Main Business
Table 126. Baxter Latest Developments
Table 127. LG Life Sciences Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 128. LG Life Sciences Pediatric Vaccines Product Portfolios and Specifications
Table 129. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. LG Life Sciences Main Business
Table 131. LG Life Sciences Latest Developments
Table 132. Lupin Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 133. Lupin Pediatric Vaccines Product Portfolios and Specifications
Table 134. Lupin Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 135. Lupin Main Business
Table 136. Lupin Latest Developments
Table 137. S K Chemicals Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 138. S K Chemicals Pediatric Vaccines Product Portfolios and Specifications
Table 139. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 140. S K Chemicals Main Business
Table 141. S K Chemicals Latest Developments
Table 142. Mitsubishi Tanabe Pharma Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 143. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolios and Specifications
Table 144. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 145. Mitsubishi Tanabe Pharma Main Business
Table 146. Mitsubishi Tanabe Pharma Latest Developments
Table 147. Janssen Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 148. Janssen Pediatric Vaccines Product Portfolios and Specifications
Table 149. Janssen Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 150. Janssen Main Business
Table 151. Janssen Latest Developments
Table 152. Shenzhen Kangtai Biological Products Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 153. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolios and Specifications
Table 154. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 155. Shenzhen Kangtai Biological Products Main Business
Table 156. Shenzhen Kangtai Biological Products Latest Developments
Table 157. Sinovac Biotech Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 158. Sinovac Biotech Pediatric Vaccines Product Portfolios and Specifications
Table 159. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 160. Sinovac Biotech Main Business
Table 161. Sinovac Biotech Latest Developments
Table 162. Bharat Biotech Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 163. Bharat Biotech Pediatric Vaccines Product Portfolios and Specifications
Table 164. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 165. Bharat Biotech Main Business
Table 166. Bharat Biotech Latest Developments
Table 167. Crucell Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 168. Crucell Pediatric Vaccines Product Portfolios and Specifications
Table 169. Crucell Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 170. Crucell Main Business
Table 171. Crucell Latest Developments
Table 172. Dynavax Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 173. Dynavax Pediatric Vaccines Product Portfolios and Specifications
Table 174. Dynavax Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 175. Dynavax Main Business
Table 176. Dynavax Latest Developments
Table 177. Serum Institute of India Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 178. Serum Institute of India Pediatric Vaccines Product Portfolios and Specifications
Table 179. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 180. Serum Institute of India Main Business
Table 181. Serum Institute of India Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pediatric Vaccines
Figure 2. Pediatric Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pediatric Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pediatric Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Diphtheria
Figure 10. Product Picture of Influenza
Figure 11. Product Picture of Hepatitis
Figure 12. Product Picture of Pneumococcal Diseases
Figure 13. Product Picture of Meningococcal Diseases
Figure 14. Product Picture of Others
Figure 15. Global Pediatric Vaccines Sales Market Share by Type in 2022
Figure 16. Global Pediatric Vaccines Revenue Market Share by Type (2018-2023)
Figure 17. Pediatric Vaccines Consumed in Newborn
Figure 18. Global Pediatric Vaccines Market: Newborn (2018-2023) & (K Units)
Figure 19. Pediatric Vaccines Consumed in Infant
Figure 20. Global Pediatric Vaccines Market: Infant (2018-2023) & (K Units)
Figure 21. Pediatric Vaccines Consumed in Child
Figure 22. Global Pediatric Vaccines Market: Child (2018-2023) & (K Units)
Figure 23. Pediatric Vaccines Consumed in Dolescent
Figure 24. Global Pediatric Vaccines Market: Dolescent (2018-2023) & (K Units)
Figure 25. Global Pediatric Vaccines Sales Market Share by Application (2022)
Figure 26. Global Pediatric Vaccines Revenue Market Share by Application in 2022
Figure 27. Pediatric Vaccines Sales Market by Company in 2022 (K Units)
Figure 28. Global Pediatric Vaccines Sales Market Share by Company in 2022
Figure 29. Pediatric Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Pediatric Vaccines Revenue Market Share by Company in 2022
Figure 31. Global Pediatric Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Pediatric Vaccines Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Pediatric Vaccines Sales 2018-2023 (K Units)
Figure 34. Americas Pediatric Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. APAC Pediatric Vaccines Sales 2018-2023 (K Units)
Figure 36. APAC Pediatric Vaccines Revenue 2018-2023 ($ Millions)
Figure 37. Europe Pediatric Vaccines Sales 2018-2023 (K Units)
Figure 38. Europe Pediatric Vaccines Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Pediatric Vaccines Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Pediatric Vaccines Revenue 2018-2023 ($ Millions)
Figure 41. Americas Pediatric Vaccines Sales Market Share by Country in 2022
Figure 42. Americas Pediatric Vaccines Revenue Market Share by Country in 2022
Figure 43. Americas Pediatric Vaccines Sales Market Share by Type (2018-2023)
Figure 44. Americas Pediatric Vaccines Sales Market Share by Application (2018-2023)
Figure 45. United States Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Pediatric Vaccines Sales Market Share by Region in 2022
Figure 50. APAC Pediatric Vaccines Revenue Market Share by Regions in 2022
Figure 51. APAC Pediatric Vaccines Sales Market Share by Type (2018-2023)
Figure 52. APAC Pediatric Vaccines Sales Market Share by Application (2018-2023)
Figure 53. China Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Pediatric Vaccines Sales Market Share by Country in 2022
Figure 61. Europe Pediatric Vaccines Revenue Market Share by Country in 2022
Figure 62. Europe Pediatric Vaccines Sales Market Share by Type (2018-2023)
Figure 63. Europe Pediatric Vaccines Sales Market Share by Application (2018-2023)
Figure 64. Germany Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Pediatric Vaccines Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Pediatric Vaccines Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Pediatric Vaccines Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Pediatric Vaccines Sales Market Share by Application (2018-2023)
Figure 73. Egypt Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Pediatric Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Pediatric Vaccines in 2022
Figure 79. Manufacturing Process Analysis of Pediatric Vaccines
Figure 80. Industry Chain Structure of Pediatric Vaccines
Figure 81. Channels of Distribution
Figure 82. Global Pediatric Vaccines Sales Market Forecast by Region (2024-2029)
Figure 83. Global Pediatric Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Pediatric Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Pediatric Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Pediatric Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Pediatric Vaccines Revenue Market Share Forecast by Application (2024-2029)